GlobeNewswire

MedSpa Board and QUAD A Provide Joint Guidance on IV Infusion Safety Following Recent Safety Concerns
06/10/2026
HIGHLAND PARK, Ill., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Following recent FDA and CDC safety communications involving compounded injectable glutathione and related adverse events, QUAD A and MedSpa Board are providing [...]
Fast Company Names Veyond Metaverse a 2026 Next Big Things in Tech Winner for OceanMD, XR Telemedicine for Ships and Remote Sites
06/10/2026
OceanMD brings a remote physician virtually beside the medic on ships and offshore sites where specialist help can be days away SAN FRANCISCO, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Veyond Metaverse , a developer of [...]
Going Beyond Addiction
06/10/2026
San Diego-based Shoreline Recovery Center highlights the importance of long-term support for individuals following addiction treatment San Diego, CA., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Achieving sobriety after addiction [...]
Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026
06/10/2026
Company to host conference call and webcast following the presentation on Tuesday, October 20, at 8:00 a.m. EDT BOSTON, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (Nasdaq: ODTX) (“Odyssey” or the “ [...]
vTv Therapeutics to Host Virtual KOL Event on Hypoglycemia in Type 1 Diabetes and the Cadisegliatin Phase 3 Program on October 20, 2026
06/10/2026
HIGH POINT, N.C., Oct. 06, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company advancing cadisegliatin, a novel oral investigational therapy for type 1 diabetes (T1D), [...]
YD Bio and EG BioMed Launch AI-Based 10-Cancer Risk Factor Assessment
06/10/2026
TAIPEI, Taiwan, and BOTHELL, Wash., Oct. 06, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and [...]
Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise
06/10/2026
Former Gilead and Amgen executive joins Entera with over 35 years of experience advancing and commercializing impactful and blockbuster therapies TEL AVIV, Israel, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. ( [...]
LB Pharmaceuticals to Host In-Person and Virtual R&D Day on October 27, 2026: Advancing LB‑102 with a Focus on Schizophrenia Treatment
06/10/2026
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that [...]
Outlook Therapeutics Highlights What the Appointment of New CFO Kevin Lundquist Means for the Company’s Next Chapter in Virtual Investor Discussion
06/10/2026
Segment features Kevin Lundquist discussing his decision to join Outlook Therapeutics and the Company’s path forward following the FDA approval of LYTENAVA™ Access the segment here ISELIN, N.J., Oct. 06, 2026 (GLOBE [...]
Ascendis to Share Latest Advances in Hypoparathyroidism and Achondroplasia Programs at ASBMR 2026
06/10/2026
COPENHAGEN, Denmark, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest advances in its hypoparathyroidism and achondroplasia programs will be showcased during ASBMR [...]
Applied Biologics Announces Manufacturing Milestone in APPB-515 Osteoarthritis Gene Therapy Program
06/10/2026
Successful production of reference protein advances proprietary protein engineering and gene therapy development program SCOTTSDALE, Ariz., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, LLC today announced the [...]
Dentsply Sirona Continues North American Commercial Expansion with Midwest Dental Agreement
06/10/2026
The expanded relationship builds on a series of agreements announced this year, strengthening Dentsply Sirona’s North American dealer network and giving more customers access to its products and technology. CHARLOTTE, N [...]
Oku Digital Health Launches Connected Care Solution to Unite Primary Care, Optometry, and Ophthalmology
06/10/2026
Launched from Topcon Healthcare, Oku Combines AI, Retinal Imaging, and Connected Clinical Data to Identify Disease Risk Earlier and Route Patients to the Right Care LA JOLLA, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) -- [...]
Oku Digital Health Launches From Topcon Healthcare to Transform Eye Care Into Whole-Body Health
06/10/2026
Built on Topcon's Global Diagnostic Network and Microsoft Azure Cloud, Oku Operationalizes Healthcare from the Eye™ Across 10,000+ Connected Sites LA JOLLA, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Oku Digital Health, [...]
Oku Digital Health Launches From Topcon Healthcare to Accelerate Drug Development Using Ocular Data
06/10/2026
Leveraging 17.1 Million Retinal Images and Point-of-Care Networks, Oku Connects Life Sciences Sponsors with Early-Stage, Treatment-Naïve Patients and Data for Drug Development LA JOLLA, Calif., Oct. 06, 2026 (GLOBE [...]
Legend Senior Living® Acquires Ashton Commons Senior Living in Wexford, Pennsylvania
06/10/2026
The addition marks Legend Senior Living’s 80th community nationwide and further expands the company’s presence in the greater Pittsburgh area Summary Legend Senior Living has acquired Ashton Commons Senior Living, a [...]
Repligen Completes Acquisition of BioLife Solutions
06/10/2026
WALTHAM, Mass., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN, “Repligen”, or the “Company”), a life sciences company focused on bioprocessing technology leadership, today announced it has [...]
Deaconess Standardizes Scheduling and Communications Operations with PerfectServe
06/10/2026
Health system establishes a centralized foundation for care team availability, operator workflows, and omnichannel communication EVANSVILLE, Ind. and MIAMI, Oct. 06, 2026 (GLOBE NEWSWIRE) -- PerfectServe®, a healthcare [...]
PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics
06/10/2026
PacBio Kinnex sequencing will generate full-length transcript data to help advance TychoBio’s drug discovery models MENLO PARK, Calif. and PARIS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum